# Post Intensive Care Unit Atrial Fibrillation

Study · id `cardio:ct-nct05860894` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05860894](<https://clinicaltrials.gov/study/NCT05860894>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05860894

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 150 participants.

## Technical summary

Registry record NCT05860894. Allocation not applicable; no masking; primary purpose diagnostic. Start 2023-09-19 (actual); primary completion 2025-04-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT05860894, source copy `cardio:ctgov-nct05860894-2026-10-22`, retrieved 2026-10-26)
- Started: 2023-09-19 (actual) (ClinicalTrials.gov record NCT05860894, source copy `cardio:ctgov-nct05860894-2026-10-22`, retrieved 2026-10-26)
- Primary completion: 2025-04-10 (actual) (ClinicalTrials.gov record NCT05860894, source copy `cardio:ctgov-nct05860894-2026-10-22`, retrieved 2026-10-26)
- Completion: 2025-04-10 (actual) (ClinicalTrials.gov record NCT05860894, source copy `cardio:ctgov-nct05860894-2026-10-22`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT05860894, source copy `cardio:ctgov-nct05860894-2026-10-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05860894-2026-10-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Post Intensive Care Unit Atrial Fibrillation
- Acronym: PIAF
- Condition: Atrial Fibrillation
- Condition: Critical Illness
- Intervention (Device): Implantable ECG holter device (Biomonitor3, Biotronik)
- Lead sponsor: Centre Hospitalier Universitaire de Besancon
- Lead sponsor class: OTHER
- Collaborator: Biotronik SE & Co. KG
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Centre Hospitalier Universitaire de Besancon (`cardio:org-centre-hospitalier-universitaire-de-besancon`)
- Registry lists this organization as a collaborator: Biotronik SE & Co. KG (`cardio:org-biotronik-se-co-kg`)

## Provenance

Content hash: a436bc746dcc6939eee74f1c900262ce53bb1d59f7775ccd307968cf692c3d78
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
